Search

everythinglearnresearchcommunity

for

Search:↓

Platelet-rich plasma (PRP) injections successfully treated a woman's steroid-resistant hair loss, causing hair to regrow within a month.

Doxycycline can effectively treat hair loss caused by EGFR inhibitors.

Baricitinib helped treat a man's beard hair loss when steroids didn't work.

Tofacitinib was effective for severe, treatment-resistant hair loss without side effects.

Cyclophosphamide helped 59.4% of children with steroid-resistant nephrotic syndrome but caused side effects in 40.6%.

A 13-year-old girl with various symptoms was successfully treated with an antibiotic called co-trimoxazole.

Steroid treatment improved both gut and nerve symptoms in a man with Cronkhite–Canada syndrome.

Tacrolimus causes fewer acute rejections than cyclosporin A in kidney transplants but doesn't necessarily improve kidney function after one year; cardiovascular risks and side effects vary between the two drugs.

Rituximab may be an effective treatment for Cronkhite-Canada syndrome with kidney disease.

People with hair loss have more androgen receptors and enzymes in certain follicles, with men and women showing different patterns.

Treatments for permanent hair loss from scarring aim to stop further loss, not regrow hair, and vary by condition, with partial success common.

New regenerative treatments for hair loss show promise but need more research for confirmation.

A 9-year-old girl with alopecia areata had successful hair regrowth using bimatoprost after other treatments failed.

Personalized treatment plans are important for people with alopecia areata.

Graft-versus-host disease is a complication where donor immune cells attack the recipient's body, often affecting the skin, liver, and gastrointestinal tract.

Cyclosporine may cause hair loss, so patients need monitoring.

Platelet-rich plasma (PRP) is a simple, cost-effective treatment that promotes hair growth and reduces hair loss, with high patient satisfaction.

Myositis in lupus patients is linked to skin rash, hair loss, blood issues, and high disease activity.

Anabolic steroids can build muscle and strength but have risks and need more research on their clinical benefits and side effects.

Tofacitinib helped a woman regrow her hair without relapses after other treatments failed.

A patient with Cronkhite-Canada Syndrome developed colon cancer that spread to the liver, showing the need for regular cancer checks in such patients.

Topical vitamin D is useful for some skin conditions but not effective for others, and more research is needed.

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

Methotrexate is not proven effective for inducing remission in ulcerative colitis.

Topical corticosteroids are the best initial treatment for children's alopecia areata.

Recombinant thrombomodulin can effectively treat severe complications in Cronkhite-Canada syndrome.

Regular endoscopic checks are crucial for Cronkhite-Canada syndrome patients to catch potential cancers early.

Regenerative therapies show promise for treating vitiligo and alopecia areata.

Different types of fibroblasts play various roles in diseases and healing, and more research on them could improve treatments.

Alopecia areata involves immune activation in the scalp, suggesting treatments targeting TH1, TH2, and IL-23 pathways.